CAMBRIDGE, Mass., March 13, 2026 /PRNewswire/ — Insilico Medicine (HKEX: 3696.HK, "Insilico" or the "Company"), a clinical-stage biotechnology company powered by generative artificial intelligence for drug discovery and development, today announced that it will report its financial results for the year ended December 31, 2025, and provide a business update on March 30, 2026. The Company will hold live conference calls in English and Mandarin on March 30, 2026, Beijing Time.

The English session of the conference call will be held at 9:00 AM on March 30, 2026, Beijing Time (9:00 PM U.S. Eastern Time on March 29, 2026), and the Mandarin session of the conference call will be held at 10:30 AM Beijing Time on the same day (10:30 PM U.S. Eastern Time on March 29, 2026).

The conference calls can be accessed by the following links:

For English Session:

Time: 9:00 AM Beijing Time, Monday, March 30, 2026
(9:00 PM U.S. Eastern Time, Sunday, March 29, 2026)

Register and Webcast Link:

https://insilico.zoom.us/w/81195639919?pwd=i153PUfkONs5INk8mgvLmmttveLqc0.1

Participants are required to pre-register for the English conference call using the link above. After registration is approved, participants will receive the webinar access link and dial-in information via email.

For Mandarin Session:

Time: 10:30 AM Beijing Time, Monday, March 30, 2026
(10:30 PM U.S. Eastern Time, Sunday, March 29, 2026)

Register and Webcast Link:
https://research.citics.com/tel/info/1_2047925

Participants are required to pre-register for the Mandarin conference call using the link above.

Alternatively, participants may dial in to the conference call using below dial-in information:

Mainland China

4008108228

Hong Kong, China

85230051313

International

861058084166

Singapore

6568185374

United States

16462543594

United Kingdom

441213680466

Password

977326

The replay of English session will be available shortly after the call and can be accessed by visiting the Company’s website at https://insilico.com/.

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Shengfeng Development Limited Enters China's Low-Altitude Logistics Sector

FUZHOU, China, Nov. 11, 2024 /PRNewswire/ — Shengfeng Development Limited ("Shengfeng" or…

Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata

Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1%…

Vantage Markets Named Top Overall Broker for Australia by Daytrading.com

SYDNEY, March 27, 2024 /PRNewswire/ — Multi-asset broker, Vantage Markets ("Vantage") is proud…